|
Jul 23
|
Ovid Therapeutics Expands Scientific Advisory Board with Appointments of Leading Neurologists, Neuroscientists and Epileptologists
|
|
Jun 20
|
Biotech Stock Roundup: ITCI Up on Study Data, ZNTL, OVID Down on Updates & More News
|
|
Jun 18
|
OVID Slumps 76% on Epilepsy Drug Failing Two Pivotal Studies
|
|
Jun 18
|
Apple downgraded, Kroger upgraded: Wall Street's top analyst calls
|
|
Dec 1
|
Ovid Therapeutics to Present Five Abstracts Supporting its Epilepsy Programs at the 77th American Epilepsy Society Annual Meeting (2023)
|